ESC 2021: Stopping Dual Antiplatelet Therapy 1 Month After Percutaneous Coronary Intervention is Not Safe in Acute Coronary Syndromes
A reduction is bleeding risk was inadequate to offset the increased risk of myocardial infarction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.